Biopharmaceutical Research Firm, WCCT Global, CEO invited to the White House
Cypress, California, San Francisco, and Philadelphia –June 7th, 2012 – WCCT Global, LLC, a full service contract research organization (CRO) supporting early phase biopharmaceutical and device development, announced Dr. Kenneth Kim, CEO & Founder, was one of 150 Korean American business and community leaders invited to the first White House initiative reaching out to the Korean American community. This unique gathering was cohosted by the CKA -Council of Korean Americans, a national, non-partisan, non-profit organization of Korean American leaders whose mission to assert a strong, clear voice on issues of critical importance to Korean Americans and to support full participation in all aspects of American life.
WCCT Global founded by Dr. Kenneth Kim in 1998 is a global provider of outsourced early drug development services to the pharmaceutical, biotechnology and medical device industries. As a drug development partner, WCCT Global partners with domestic and foreign innovator companies who need Regulatory, ProgramManagement, Data Management, Bio Statistics and strategic Consulting Support from First-in-Man thru the proof of concept stage with an emphasis on overseeing and executing on trials in special disease populations,ethnobridging volunteers, and cardiac safety studies.
Mr. Jon Rojas COO, said, “We are very proud and honored to have Dr. Kim represent our company at this historic event. His in-depth knowledge as a clinician and his extensive experience in clinical trials has enabled us to continually grow and service our clients even in these difficult times. Dr kim added, “it was interesting to see the administration’s effort in reaching out to the small business community where Korean American owned businesses account for about 50% of the economic output of minority owned small businesses in the US.”
Request more information about WCCT Global capabilities Here